Competitor Profiling: National Cancer Institute vs. NCI Alliance for Nanotechnology in Cancer

Competitor Profiling: National Cancer Institute vs. NCI Alliance for Nanotechnology in Cancer

National Cancer Institute

Overview (Name of Competitor and Size/Volume)

The operations of National Cancer Institute (NCI) are facilitated under the standardized regulations imposed by National Institutes of Health (NIH). NCI is a subsidiary of the NIH along with other agencies that operate in the healthcare industry of the United States. The policies applicable on the practice of NIH and NCI are constructed by Department of Health and Human Services; moreover, this organization is responsible for budget allocation for different research projects and healthcare programs (Lynch, et al. 2006, 44-63). The regulations imposed on NCI are classified by National Cancer Institute Act 1937. This Act has been passed by the initiatives of federal government in order to facilitate the cure for cancer and its effective treatment in the country. The inception of NCI was acknowledged in 1971 due to the enhancement in the scope of the Act.

Since then, NCI is striving to facilitate the cure for cancer and has initiated several research programs to achieve its objective. There have been several amendments in the Act which refined the regulations imposed on the organization. NCI has initiated several healthcare programs in order to implement effective cures of cancer in clinical practice. Nonetheless, the organization is continuously growing and enhancing its capabilities to achieve its objectives. The operations of the organization are facilitated by sophisticated practices of its R&D department that is not only responsible for finding cure alternatives for cancer but also analyze the competitor analysis. The organization is equipped with the most qualified human resource. In addition, the operations of the organization include R&D, health information dissemination and initiation of diverse programs that are entitled to cure, prevention and rehabilitation of cancer patients along with the implication of the discovered approaches in the clinical practice.

Nature of Organization/Operation

National Cancer Institute operates in the healthcare industry of the United States in order to explore and imply contemporary treatment alternatives of the disease in the clinical practice. The operations of the organization are aimed at initiating and financing different programs that facilitate cancer treatment. The organization explores the treatment of the disease through which the patient can be treated even though he has reached the critical stage. Nonetheless, organization's operations are responsible for initiating different programs that are entitled to extinct cancer from the United States (Henderson, Ponder, Ross, 2003, 86-92).

Competitive Strength

The competitive strength of the organization is the sophisticated practices of its R&D department. The operations of R&D department in National Cancer Institute are regulated by skilled and qualified resource. This department is not only responsible for exploring the optimal methods of cancer treatment but the operations of the department are entitled to achieve competitive greatness in the industry. In addition, the organization is also equipped with contemporary technology adaptation as the tools and equipments used in the organization are highly effective for treating the patients and carrying out the ...